(Q82876167)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

Gregory Poland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

7

Myron J Levin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Joost N Vermeulen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Joep M A Lange

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stephen K Tyring

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Patrick H Peters

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Margaret Nunez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carrie Freeman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ira Chalikonda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jianjun Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jeffrey G Smith

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michael J Caulfield

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jon E Stek

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ivan S F Chan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rupert Vessey

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Florian P Schödel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paula W Annunziato

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Katia Schlienger

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jeffrey L Silber

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

7 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

904-910

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

Clinical practice. Herpes zoster

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Selective decline in cellular immune response to varicella-zoster in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Lymphocyte responses to varicella zoster virus in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Immune response of elderly individuals to a live attenuated varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.096

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.11.096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154769%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference